This breast cancer drug is first in new class of chemo agents
Submitted by eport on Mon, 12/10/2007 - 05:00.
The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine
(Xeloda) for patients with metastic or locally advanced breast cancer.
»
- Login or register to post comments
- Feed: New Rx: Drug Topics
- Original article




